Pharmacokinetics of Compound Enalapril-Felodipine Extended Release Tablets in Chinese Healthy Subjects

LIU Shanjun,ZHOU Wenjia,HUANG Yan,LIU Xiaoxue,DING Li

DOI: https://doi.org/10.3969/j.issn.1001-5094.2013.01.006

2013-01-01

Abstract:Objective:To study the pharmacokinetics of compound enalapril-felodipine extended release tablets in Chinese healthy subjects.Methods:12 healthy subjects(half male and half female) were randomly divided into 2 groups,and administered the low dose of the test preparations(felodipine 5 mg/enalapril maleate 5 mg) and two kinds of reference preparations(felodipine 5 mg + enalapril maleate 5 mg) in a single-dose,then a 7-day multi-dose,under the two-way crossover design.After the above study,all the subjects were administered the single high dose of the test preparations(felodipine 10 mg/ enalapril maleate 10 mg).The concentration of felodipine,enalapril and the active metabolite enalaprilat in human plasma was determined by LC-MS method.The pharmacokinetic parameters were calculated and the related statistical analysis was conducted.Results:In the single low-dose study,the pharmacokinetic parameters of felodipine,enalapril and enalaprilat did not show a statistically significant difference between the subjects administered test preparations and those administered reference preparations(P0.05).In the multiple low-dose study,the pharmacokinetic parameters of felodipine,enalapril and enalaprilat did not show a statistically significant difference(P0.05) except that the Tmax of the enalaprilat in subjects administered test preparations was about 0.6 h earlier than that of subjects admi-nistered reference preparations(P0.05).In both of the single low dose and single high dose experiments,the AUC and Cmax values of felodipine,enalapril and enalaprilat increased with the increase of the dosage.The pharmacokinetic parameters of felodipine,enalapril and enalaprilat did not show a statistically significant difference(P0.05) except that the Tmax of the enalapril in the subjects administered high-dose lagged about 0.4 h compared with that of the subjects administered low-dose(P0.05).No statistically significant difference of pharmacokinetic parameters was observed between two genders(P0.05).Conclusion:The LC-MS method established for the determination of felodipine,enalapril and enalaprilat in human plasma was proved to have good accuracy,precision,stability and linear relationship.It meets the requirement for the analysis of biological specimen,and is suitable for study on pharmacokinetics of compound enalapril-felodipine extended release tablets in healthy subjects.The pharmacokinetic process of the tested preparation and two kinds of reference preparations in human body is basically identical.